HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Markku Kaste Selected Research

Ancrod (Arvin)

12/2009Ancrod in acute ischemic stroke: results of 500 subjects beginning treatment within 6 hours of stroke onset in the ancrod stroke program.
5/2009Hyperfibrinogenemia and functional outcome from acute ischemic stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Markku Kaste Research Topics

Disease

75Stroke (Strokes)
12/2022 - 01/2002
55Ischemic Stroke
12/2022 - 01/2002
12Hemorrhage
10/2014 - 07/2004
10Infarction (Infarctions)
02/2022 - 01/2002
7Hypertension (High Blood Pressure)
12/2019 - 01/2006
5Intracranial Hemorrhages (Intracranial Hemorrhage)
12/2016 - 09/2008
5Cerebral Hemorrhage
01/2014 - 12/2008
3COVID-19
10/2021 - 01/2021
3Atrial Fibrillation
02/2021 - 02/2015
3Heart Failure
02/2021 - 12/2008
3Dementia (Dementias)
02/2021 - 10/2003
3Pathologic Constriction (Stenosis)
12/2016 - 01/2005
3Carotid Stenosis (Carotid Artery Stenosis)
10/2013 - 07/2003
3Carotid Artery Diseases
06/2007 - 01/2005
3Cerebral Infarction
01/2006 - 01/2002
2Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
06/2021 - 06/2015
2Dyslipidemias (Dyslipidemia)
12/2019 - 08/2011
2Cardiovascular Diseases (Cardiovascular Disease)
11/2018 - 10/2013
2Myocardial Infarction
12/2015 - 01/2004
2Diabetes Mellitus
02/2015 - 08/2011
2Transient Ischemic Attack
05/2014 - 08/2011
2Ischemia
06/2013 - 11/2009
2Depressive Disorder (Melancholia)
01/2013 - 01/2003
2Thrombosis (Thrombus)
01/2009 - 01/2004
2Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
01/2009 - 06/2007
2Cognitive Dysfunction
10/2008 - 11/2007
1Paresis (Hemiparesis)
02/2022
1Intracranial Sinus Thrombosis (Sinus Thrombosis)
10/2021
1Infections
01/2021
1Homozygous Familial Hypercholesterolemia
01/2021
1Atherosclerosis
12/2019
1Neoplasms (Cancer)
11/2018
1Type 2 Diabetes Mellitus (MODY)
11/2018
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2018
1Perinatal Death
12/2017
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
02/2015
1Inflammation (Inflammations)
10/2014
1Atherosclerotic Plaque (Atheroma)
10/2014
1Embolism (Embolus)
05/2014
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2014
1Edema (Dropsy)
10/2013
1Hemianopsia (Bitemporal Hemianopsia)
10/2012

Drug/Important Bio-Agent (IBA)

24Tissue Plasminogen Activator (Alteplase)FDA Link
01/2018 - 01/2003
8Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2021 - 02/2003
7LipidsIBA
01/2021 - 01/2005
74- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA
08/2016 - 01/2007
7Blood Glucose (Blood Sugar)IBA
02/2015 - 12/2008
6Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2014 - 01/2004
6Glucose (Dextrose)FDA LinkGeneric
07/2013 - 10/2008
5Clopidogrel (Plavix)FDA Link
05/2014 - 01/2004
4Antihypertensive Agents (Antihypertensives)IBA
01/2019 - 07/2009
4Desmodus rotundus salivary plasminogen activator alpha 1IBA
12/2016 - 01/2005
3Antidepressive Agents (Antidepressants)IBA
12/2022 - 01/2003
3LDL CholesterolIBA
01/2021 - 01/2005
3Fibrinogen (Factor I)FDA Link
06/2014 - 01/2007
2Triglycerides (Triacylglycerol)IBA
11/2018 - 01/2005
2HDL CholesterolIBA
11/2018 - 01/2005
2HaptoglobinsIBA
01/2017 - 10/2013
2FibrinIBA
06/2015 - 01/2005
2Plasminogen Activators (Plasminogen Activator)IBA
06/2015 - 02/2009
2IronIBA
10/2013 - 01/2007
2danaparoid (Orgaran)FDA Link
01/2011 - 04/2009
2Ancrod (Arvin)IBA
12/2009 - 05/2009
2Telmisartan (Micardis)FDA Link
10/2008 - 09/2008
2Dipyridamole (Persantine)FDA LinkGeneric
10/2008 - 09/2008
2Angiotensin Receptor AntagonistsIBA
10/2008 - 09/2008
2Neuroprotective AgentsIBA
10/2008 - 01/2005
2CholesterolIBA
06/2007 - 01/2005
2Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2006 - 09/2004
2Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2006 - 01/2005
2ZK 200775IBA
01/2005 - 12/2002
2alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
01/2005 - 12/2002
2Pharmaceutical PreparationsIBA
01/2005 - 12/2002
2Hypnotics and Sedatives (Sedatives)IBA
01/2005 - 01/2003
1Lipoprotein(a)IBA
10/2021
1oxidized low density lipoproteinIBA
01/2021
1TenecteplaseFDA Link
01/2021
1DNA (Deoxyribonucleic Acid)IBA
12/2019
1insulin receptor-related receptor (IRR)IBA
12/2017
1Warfarin (Coumadin)FDA LinkGeneric
05/2014
1Hemoglobins (Hemoglobin)IBA
10/2013
1Heme (Haem)IBA
10/2013
1LDL Lipoproteins (beta Lipoproteins)IBA
08/2013
1Free Radical ScavengersIBA
01/2013
1EdaravoneIBA
01/2013
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
10/2012

Therapy/Procedure

14Therapeutics
06/2021 - 01/2002
10Thrombolytic Therapy
01/2016 - 01/2003
5Treatment Delay
08/2016 - 10/2013
4Time-to-Treatment
08/2016 - 05/2010
3Secondary Prevention
09/2014 - 08/2011
2Length of Stay
02/2021 - 01/2009
2Institutionalization (Institutionalized Persons)
02/2021 - 12/2015
2Transcranial Magnetic Stimulation
01/2015 - 03/2012
2Intravenous Infusions
01/2013 - 05/2009
2Activities of Daily Living (ADL)
11/2007 - 10/2003
2Carotid Endarterectomy
01/2005 - 07/2003
1Endovascular Procedures
02/2015
1Aftercare (After-Treatment)
11/2014
1Resuscitation Orders (Do Not Resuscitate Orders)
01/2014